AI Body Composition Measurements can Predict Cardiometabolic Risk

Adiposity - or the accumulation of excess fat in the body - is a known driver of cardiometabolic diseases such as heart disease, stroke, type 2 diabetes, and kidney disease. But getting the full picture of a person’s risk is harder than it may seem. Traditional measures such as body mass index (BMI) are imperfect, conflating fat and muscle mass and not capturing where in the body fat is located. A new study from researchers at Mass General Brigham and their colleagues found that an AI tool designed to measure body composition could accurately capture details in just three minutes from a body scan. Their results, published in Annals of Internal Medicine, show that not all fat is equally harmful and highlight the potential of using AI to repurpose data from routine scans.

"We are hoping that these findings could be used to develop an ‘opportunistic screening’ tool to repurpose existing MRI and CT scans taken at the hospital to find patients with high-risk body composition who may be flying under the radar and could benefit from targeted diabetes and cardiovascular disease prevention," said co-senior author Vineet K. Raghu, PhD, a computational scientist with the Mass General Brigham Heart and Vascular Institute.

Raghu and colleagues conducted a prospective cohort study using data from the U.K. Biobank. The researchers used whole-body MRIs from more than 33,000 adults with no prior history of diabetes or cardiovascular events who were followed for a median of 4.2 years.

The team found that in both men and women, AI-derived visceral adipose tissue volume (fat surrounding the abdominal organs) and fat deposits in muscle were strongly associated with diabetes and cardiovascular disease risk beyond standard measures of obesity like BMI and waist circumference. In men only, lower skeletal muscle volume was strongly associated with risk.

The authors note that future studies are needed to determine if their findings are generalizable and if AI can reliably measure these body composition metrics from routine scans. With further validation, an AI-driven approach could help leverage routine imaging to identify patients at high risk.

Jung M, Reisert M, Rieder H, Rospleszcz S, Lu MT, Bamberg F, Raghu VK, Weiss J.
Association Between Body Composition and Cardiometabolic Outcomes: A Prospective Cohort Study.
Ann Intern Med. 2025 Sep 30. doi: 10.7326/ANNALS-24-01863

Most Popular Now

ChatGPT 4o Therapeutic Chatbot 'Ama…

One of the first randomized controlled trials assessing the effectiveness of a large language model (LLM) chatbot 'Amanda' for relationship support shows that a single session of chatbot therapy...

AI Tools Help Predict Severe Asthma Risk…

Mayo Clinic researchers have developed artificial intelligence (AI) tools that help identify which children with asthma face the highest risk of serious asthma exacerbation and acute respiratory infections. The study...

AI Distinguishes Glioblastoma from Look-…

A Harvard Medical School–led research team has developed an AI tool that can reliably tell apart two look-alike cancers found in the brain but with different origins, behaviors, and treatments. The...

Overcoming the AI Applicability Crisis a…

Opinion Article by Harry Lykostratis, Chief Executive, Open Medical. The government’s 10 Year Health Plan makes a lot of the potential of AI-software to support clinical decision making, improve productivity, and...

Smart Device Uses AI and Bioelectronics …

As a wound heals, it goes through several stages: clotting to stop bleeding, immune system response, scabbing, and scarring. A wearable device called "a-Heal," designed by engineers at the University...

Dartford and Gravesham Implements Clinis…

Dartford and Gravesham NHS Trust has taken a significant step towards a more digital future by rolling out electronic test ordering using Clinisys ICE. The trust deployed the order communications...

AI Body Composition Measurements can Pre…

Adiposity - or the accumulation of excess fat in the body - is a known driver of cardiometabolic diseases such as heart disease, stroke, type 2 diabetes, and kidney disease...